Indian American’s business receives US$400,000 NCI/NIH Grant to treat lung cancer

Three company's immunotherapy program does not use viruses that are conventionally used for treatments of such kind, it has the potential to become the first of its kind approach for cancer immunotherapy.

Avani Acharya

This post is for paying subscribers only


Already have an account? Login